Skip to main content

Table 1 Observed seroprevalence versus fitted seroprevalence for the the case of constant domestic (β ij = β ¯ MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacuWFYoGygaqeaaaa@2E6C@ ij ) and travel (τ i = τ ¯ MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacuWFepaDgaqeaaaa@2E90@ i ) transmission rates, and for the case of time-varying domestic (β ij = β ij (t)) and travel (τ i = τ i (t)) transmission rates.

From: Cohort effects in dynamic models and their impact on vaccination programmes: an example from Hepatitis A

  Seroprevalence
Age class, year, survey Observed Fitted, without cohort effect Fitted, with cohort effect
0–4, 1981, Ref. 58 0.0024 0.014 0.009
5–9, 1981, Ref. 58 0.0024 0.047 0.030
10–19, 1988, Ref. 59 0.0063 0.068 0.046
10–19, 1995, Ref. 27 0.0299 0.068 0.048
10–19, 1981, Ref. 57 0.0632 0.068 0.049
20–29, 1988, Ref. 59 0.103 0.082 0.064
20–29, 1980, Ref. 57 0.114 0.082 0.129
30–39, 1988, Ref. 59 0.287 0.097 0.171
40–59, 1980, Ref. 57 0.599 0.115 0.618
40–59, 1988, Ref. 59 0.550 0.115 0.491
60+, 1988, Ref. 59 0.820 0.137 0.745
  1. The seroprevalence values listed under "Observed", "Without cohort effect" (fitted model, constant case) and "With cohort effect" (fitted model, time-varying case) are for the timepoints specified in the first column.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us